Relmada Therapeutics, Inc. (NASDAQ:RLMD – Get Free Report) was the target of a large decrease in short interest in December. As of December 15th, there was short interest totalling 638,800 shares, a decrease of 26.2% from the November 30th total of 865,800 shares. Based on an average daily volume of 172,800 shares, the days-to-cover ratio […]